Treatment of eosinophilic pustular folliculitis with tacrolimus ointment.
We describe a patient with eosinophilic pustular folliculitis who partially responded to oral indomethacin, but intermittently experienced new eosinophilic pustular folliculitis lesions. Treatment with tacrolimus ointment 0.1% resulted in the rapid improvement of each recurred lesion and allowed withdrawal of indomethacin. To our knowledge, this is the first report of the use of topical tacrolimus in the treatment of eosinophilic pustular folliculitis.
Hara
Dai
D
Department of Dermatology, National Defence Medical College, Tokorozawa, Japan.
Kuroda
Kei
K
Mieno
Hideki
H
Tajima
Shingo
S
D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000188:drug therapy*; D005499:Folliculitis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007213:Indomethacin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009824:Ointments; D012008:Recurrence; D016559:Tacrolimus / Q000008:administration & dosage*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus; D007213:Indomethacin